Structure |
Chemical Name |
CAS |
MF |
|
Dolutegravir Impurity 18 |
|
|
|
PeraMpanel |
380918-53-6 |
C23H15N3O |
|
Lenvatinib Impurity 33 |
|
|
|
isopropyl 2-(2-oxopyrrolidin-1-yl)acetate |
1249080-59-8 |
C9H15NO3 |
|
Pitavastatin Impurity 71 |
|
|
|
Rosuvastatin EP Impurity M Sodium Salt |
|
|
|
Furosemide impurity 8 |
|
|
|
Febuxostat Impurity 108 |
|
|
|
Flucloxacillin EP Impurity J |
|
|
|
Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, mono[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl] ester |
1878175-77-9 |
C17H23N10O4P |
|
Hexanoic acid, 3-formyl-, ethyl ester |
54374-02-6 |
C9H16O3 |
|
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)- |
154877-92-6 |
C9H16O5 |
|
INDEX NAME NOT YET ASSIGNED |
2463617-49-2 |
C51H56N16O4 |
|
Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]- |
906673-43-6 |
C14H11BO5 |
|
1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- |
2138805-26-0 |
C25H29ClN8O2 |
|
1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo- |
1651211-78-7 |
C19H27I2N3O9 |
|
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
|
(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide |
|
|
|
Lenvatinib impurity LFZZ-10 |
|
C11H8Cl2N2O2 |
|
(2S,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate |
|
|
|
Febuxostat Impurity 98 |
|
|
|
(2-(methyl((vinyloxy)carbonyl)amino)pyridin-3-yl)methyl 2-(methylamino)acetate hydrochloride |
|
|
|
1-(4-bromo-3,5-dimethoxyphenyl)ethanone |
1333472-28-8 |
C10H11BrO3 |
|
Ticagrelor Impurity 117 |
|
|
|
Ticagrelor Impurity 136 |
|
|
|
Vonoprazan Impurity B-2 |
|
|
|
2-(Cyanomethylthio)acetic acid |
55817-29-3 |
C4H5NO2S |
|
Budesonide Impurity 31 |
|
|
|
Budesonide Impurity 23 |
|
|
|
Hexanoic acid, 3-(chloromethyl)-, (3R)- |
2101641-90-9 |
C7H13ClO2 |
|
Bisoprolol Impurity |
2226263-68-7 |
C18H31NO4 |
|
2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)- |
1261219-83-3 |
C18H17NO4 |
|
Tofacitinib Impurity |
2504210-41-5 |
C29H38N10O2 |
|
tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate |
|
|
|
2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)- |
2459302-85-1 |
C21H27N7O3 |
|
(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) |
96946-55-3 |
C53H72N2O12+2 |
|
Glycine, N-(2-aminobenzoyl)-, ethyl ester |
5973-34-2 |
C11H14N2O3 |
|
3,3a,4,5,6,6a-ヘキサヒドロシクロペンタ[c]ピロール-2(1H)-アミン |
54528-00-6 |
C7H14N2 |
|
(S)-Methyl 2-aminobutanoate |
15399-22-1 |
C5H11NO2 |
|
(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
|
|
|
(3R)-3α,4α-(1,3-ジベンジルウレイレン)テトラヒドロチオフェン-5-オン |
28092-52-6 |
C19H18N2O2S |
|
(2S)-2-ピロリジンカルボン酸メチル |
2577-48-2 |
C6H11NO2 |
|
sodium (S,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate |
|
|
|
2,4,6-トリプロピル-1,3,5-トリオキサン |
2396-43-2 |
C12H24O3 |
|
Oseltamivir Impurity 94 |
|
|
|
Oseltamivir Impurity 82 |
|
|
|
Oseltamivir Impurity 74 |
|
|
|
Uridine, 5'-(2-methylpropanoate) (9CI) |
886538-48-3 |
C13H18N2O7 |
|
Dapagliflozin Impurity 47 |
|
|
|
Crisaborole Impurity 17 |
|
|
|
Crisaborole Impurity 19 |
|
|
|
1,5-Pentanedione, 1-(2-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]- |
2514695-40-8 |
C20H18FNO4 |
|
4-エトキシ-3-(4-ピリジニル)-3-ブテン-2-オン |
88349-61-5 |
C11H13NO2 |
|
2,3-ジヒドロ-4-メチル-1H-1,5-ベンゾジアゼピン-2-オン |
6276-48-8 |
C10H10N2O |
|
7H-Purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, ethyl ester |
7029-96-1 |
C11H14N4O4 |
|
N-(2-Amino-4,5,6,7-tetrahydro-benzothiazol-6-yl)-acrylamide |
|
|
|
Rifampin Impurity 6 |
|
|
|
Cefuroxime Dioxide Impurity(Cefuroxime Sulfoxide) |
|
|
|
Ampicillin Impurity F(USP) |
|
|
|
Miconazole Impurity G(EP) |
1370335-40-2 |
C18H14Cl4N2O |
|
2-chloro-1-(5-hydroxy-5H-chromeno[2,3-b]pyridin-7-yl)propan-1-one |
|
|
|
2-(5H-chromeno[2,3-b]pyridin-7-yl)acrylic acid |
52549-22-1 |
C15H11NO3 |
|
1-(6-chloro-5-fluoropyrimidin-4-yl)ethanol |
1289559-76-7 |
C6H6ClFN2O |
|
Phenol, 2-(diphenylmethyl)-5-methyl- |
411239-19-5 |
C20H18O |
|
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-3-(1-ethylpropoxy)-5-(formylamino)-, ethyl ester, (3R,4R,5S)- |
2148317-96-6 |
C17H28N2O5 |
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(5-chloro-2-ethoxyphenyl)-5-methyl-7-propyl- |
2245167-80-8 |
C17H19ClN4O2 |
|
Posaconazole impurity 18 |
1819334-66-1 |
C44H49F2N8O4+ |
|
(4S,6R)-6-(2-(tert-butoxy)-2-oxoethyl)-2,2-dimethyl-1,3-dioxane-4-carboxylic acid |
2095786-11-9 |
C13H22O6 |
|
Crisaborole intermediate |
2354382-27-5 |
C14H8BCl2NO3 |
|
Ropivacaine Impurity 48 |
|
|
|
2(3H)-Furanone, dihydro-4-(1-methylethyl)-, (4S)- |
53657-15-1 |
C7H12O2 |
|
Crisaborole Impurity 9 HCl |
1187187-01-4 |
C14H15BClNO3 |
|
2H-Indol-2-one, 3-[[3,5-dimethyl-4-(1-pyrrolidinylcarbonyl)-1H-pyrrol-2-yl]methylene]-5-fluoro-1,3-dihydro- |
2135339-43-2 |
C20H20FN3O2 |
|
Nicergoline Impurity 02 |
|
|
|
Bromhexine ImpurityABCDEFGHJKL |
|
|
|
1-Butanone, 1-(4-fluorophenyl)-4-[(6bR,10aR)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]- |
1576240-16-8 |
C24H28FN3O |
|
impurity 37 |
|
|
|
sodium (6R,7S)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl- 1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
|
1,4,7,10-Tetraazacyclododecane-1,4-diacetic acid |
229312-34-9 |
C12H24N4O4 |
|
Pentanoic acid, 3-(bromomethyl)-4-methyl-, ethyl ester, (3S)- |
2432911-38-9 |
C9H17BrO2 |
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[5-[(4-ethyl-1-piperazinyl)sulfonyl]-2-hydroxyphenyl]-5-methyl-7-propyl- |
2411340-39-9 |
C21H28N6O4S |
|
3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-[7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]- |
1187595-89-6 |
C17H19N7O3S |
|
4-methyl-N-(2-(methylamino)phenyl)-2-propyl-1H-benzo[d]imidazole-6-carboxamide |
884330-18-1 |
C19H22N4O |
|
2,4(1H,3H)-Pyrimidinedione, 5-(2-fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3-[(2R)-2-(hydroxyamino)-2-phenylethyl]-6-methyl- |
2486454-64-0 |
C28H24F5N3O4 |
|
3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-hydroxyphenyl)amino]-6-hydroxy-7-[3-(4-methyl-1-piperazinyl)propoxy]- |
2468737-94-0 |
C24H25Cl2N5O3 |
|
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 2,3,6b,7,8,9,10,10a-octahydro-, (6bR,10aS)- |
313368-81-9 |
C13H17N3 |
|
Ergoline-8-methanol, 1,6-dimethyl-, (8β)- (9CI) |
40170-12-5 |
C17H22N2O |
|
Cisatracurium besylate impurity 16 |
|
|
|
1-ACETYL-2-METHYLBENZIMIDAZOLE |
14678-81-0 |
C10H10N2O |
|
(E)-3-(2-Formylphenyl)-2-propenoic acid 1,1-dimethyl ethyl ester |
103890-69-3 |
C14H16O3 |
|
Bimatoprost Impurity 22 |
|
|
|
Bumetanide Impurity 9 |
|
|
|
Crisaborole Impurity 14 |
|
|
|
Benzonitrile, 4-[(1E)-4-(dimethylamino)-1-(4-fluorophenyl)-1-buten-1-yl]-3-(hydroxymethyl)- |
1370643-23-4 |
C20H21FN2O |
|
Latamoxef impurity B |
|
|
|
3-メトキシモルフィナン-17-カルボアルデヒド |
28973-48-0 |
C18H23NO2 |
|
3-(7,8-dimethoxy-2-oxo-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)-N-(((S)-3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)-N-methylpropan-1-amine oxide |
2511244-97-4 |
C27H36N2O6 |
|
Labetalol EP Impurity I |
|
|
|
Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-chloro-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl- |
2443747-63-3 |
C19H20BrClN6O4S |
|
3-オキソ-1,2-ベンゾイソチアゾリン-2-酢酸メチルエステル1,1-ジオキシド(PIROXICAM IMPURITY D)ピルオキシカム不純物D |
6639-62-9 |
C10H9NO5S |